BPC
RGNX icon

Banque Pictet & Cie’s Regenxbio RGNX Stock Holding History

Banque Pictet & Cie’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-32,167
Closed -$850K – 647
2022
Q3 		$850K Sell
32,167
-36,208
-53% -$1.07M 0.01% 419
2022
Q2 		$1.69M Sell
68,375
-6,588
-9% -$165K 0.02% 332
2022
Q1 		$2.49M Buy
74,963
+2,901
+4% +$80.6K 0.02% 294
2021
Q4 		$2.36M Buy
+72,062
New +$2.45M 0.02% 311

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Banque Pictet & Cie's RGNX Position: Q4 2022 in Review

Banque Pictet & Cie sold out of Regenxbio (RGNX) in Q4 2022, closing a stake of 32,167 shares — an estimated $850K sold.

Banque Pictet & Cie first reported a position in RGNX in Q4 2021 and held it in 4 quarters. The position peaked at $2.49M in Q1 2022. 180 funds tracked by Wall St. Rank hold RGNX as of Q4 2022.

  • Banque Pictet & Cie reported no remaining Regenxbio position as of Q4 2022 after selling out during the quarter.
  • Banque Pictet & Cie sold 32,167 Regenxbio shares in Q4 2022, an estimated $850K.
  • Banque Pictet & Cie first reported a position in Regenxbio in Q4 2021 and held it in 4 quarters.
  • Banque Pictet & Cie's Regenxbio position peaked at $2.49M in Q1 2022.
  • 180 funds tracked by Wall St. Rank held Regenxbio as of Q4 2022.

Based on Banque Pictet & Cie's 13F filing for Q4 2022, filed 6 Feb 2023.